CD8A and myeloid sarcoma: However, the lack of plasma viral load elevation during these active phases compared to healthy subjects suggests that the fluctuation in the number of specific CD8+ T cells in MS patients is not the result of a systemic control deficiency but rather a local control failure in an immune privileged site such as the CNS [100].